In summary, our research uncovered the interesting role of ketamine in TNF-α-induced SIRS, which inhibits necroptosis by affecting RIP1 ubiquitination levels and the formation of necrosomes and reducing the release of inflammatory cytokines. Here, RIPK1 is linked to systemic inflammatory response syndrome.